Novartis target Morphosys multiplies losses - takeover schedule stands

Drug discovery company Morphosys, which is about to be taken over by Novartis, has slipped deep into the red at the beginning of the year. On balance, the loss from continuing operations in the first...

Related Keywords

Germany ,Planegg ,Bayern ,United States ,Austria ,Switzerland ,Munich ,Swiss ,Jean Paul Kress ,Novartis ,Paul Kress ,Markets ,